Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Chapin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 2006 - 2010- Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 2004 - 2006
Georgetown University School of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2010 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
American Board of Urology Urology- Join now to see all
Clinical Trials
- Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) Start of enrollment: 2013 Mar 18
- NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial Start of enrollment: 2024 Mar 29
Roles: Contact
Publications & Presentations
PubMed
- Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprost...Comron Hassanzadeh, Osama Mohamad, Teresa Bruno, Lin Wang, Rajat Kudchakar
Brachytherapy. 2025-01-03 - 1 citationsWhole-body MRI for staging prostate cancer: a narrative review.Andrew M Fang, Justin R Gregg, Curtis Pettaway, Jingfei Ma, Janio Szklaruk
BJU International. 2025-01-01 - Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance.Justin R Gregg, Lisa Newcomb, Ranran Wu, Jennifer Dennison, John W Davis
Biomarker Research. 2024-11-09
Lectures
- Complex biologic heterogeneity of de novo hormone naïve metastatic prostate cancer (HNPCa): Comparison of early progressors and prolonged responders to initial system...2019 ASCO Annual Meeting - 6/1/2019
- 7th Urologic Oncology: Advances in Clinical PracticeThe University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 11/2/2012
Press Mentions
2021 Urology Care Foundation Research Scholar Awardees AnnouncedApril 13th, 2021- Two-Time Cancer Survivor: MD Anderson Is Helping Me Beat the OddsDecember 1st, 2020
Preoperative mpMRI Possibly Beneficial in High-Risk Prostate CancerSeptember 16th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
